Time to Treatment: Measuring Quality Breast Cancer Care

Annals of Surgical Oncology

Volumn 23, Issue 10, 2016, Pages 3392-3402

  Polverini, Amy C ^a   Nelson, Rebecca A ^a   Marcinkowski, Emily ^a   Jones, Veronica C ^a   Lai, Lily ^a   Mortimer, Joanne E ^a   Taylor, Lesley ^a   Vito, Courtney ^a   Yim, John ^a   Kruper, Laura ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; BLACK PERSON; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER HORMONE THERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CAUCASIAN; CHARLSON COMORBIDITY INDEX; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MASTECTOMY; MEDICAID; MEDICARE; MULTIMODALITY CANCER THERAPY; OVERALL SURVIVAL; TIME TO TREATMENT; TREATMENT OUTCOME; ADOLESCENT; AFRICAN AMERICAN; AGE; BREAST TUMOR; COMORBIDITY; EPIDEMIOLOGY; FACTUAL DATABASE; HEALTH CARE QUALITY; MIDDLE AGED; MORTALITY; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; STANDARDS; STATISTICS AND NUMERICAL DATA; SURVIVAL RATE; UNITED STATES; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AFRICAN AMERICANS; AGE FACTORS; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; COMORBIDITY; DATABASES, FACTUAL; FEMALE; HUMANS; MASTECTOMY; MEDICAID; MEDICARE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM STAGING; PROPORTIONAL HAZARDS MODELS; QUALITY INDICATORS, HEALTH CARE; SURVIVAL RATE; TIME-TO-TREATMENT; UNITED STATES; YOUNG ADULT;

EID: 84981215092     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-016-5486-7     Document Type: Article

References (27)

1. Hewitt M, Simone JV. Ensuring quality cancer care. Washington DC: National Academies Press; 1999.
2. NCCN quality measures in breast cancer. Available at: http://www.instituteforquality.org/asco-nccn-quality-measures. Accessed 10 Feb 2016.
3. Del Turco MR, Ponti A, Bick U, et al. Quality indicators in breast cancer care. Eur J Cancer. 2010;46(13):2344–56.
4. Kaufman CS, Shockney L, Rabinowitz B, et al. National Quality Measures for Breast Centers (NQMBC): a robust quality tool: breast center quality measures. Ann Surg Oncol. 2010;17(2):377–85.
5. McCahill LE, Privette A, James T, et al. Quality measures for breast cancer surgery: initial validation of feasibility and assessment of variation among surgeons. Arch Surg. 2009;144(5):455–62 (discussion 462–53).
6. Rose C, Stovall E, Ganz PA, Desch C, Hewitt M. Cancer quality alliance: blueprint for a better cancer care system. CA Cancer J Clin. 2008;58(5):266–92.
7. Malin JL, Schneider EC, Epstein AM, Adams J, Emanuel EJ, Kahn KL. Results of the National Initiative for Cancer Care Quality: how can we improve the quality of cancer care in the United States? J Clin Oncol. 2006;24(4):626–34.
8. Wilson AR, Marotti L, Bianchi S, et al. The requirements of a specialist breast centre. Eur J Cancer. 2013;49(17):3579–87.
9. Bleicher RJ, Ciocca RM, Egleston BL, et al. Association of routine pretreatment magnetic resonance imaging with time to surgery, mastectomy rate, and margin status. J Am Coll Surg. 2009;209(2):180–7 (quiz 294–185).
10. Pesce CE, Liederbach E, Czechura T, Winchester DJ, Yao K. Changing surgical trends in young patients with early stage breast cancer, 2003 to 2010: a report from the National Cancer Data Base. J Am Coll Surg. 2014;219(1):19–28.
11. Boudreau RM, McNally C, Rensing EM, Campbell MK. Improving the timeliness of written patient notification of mammography results by mammography centers. Breast J. 2004;10(1):10–19.
12. Brewer NT, Salz T, Lillie SE. Systematic review: the long-term effects of false-positive mammograms. Ann Intern Med. 2007;146(7):502–10.
13. Ferrante JM, Chen PH, Kim S. The effect of patient navigation on time to diagnosis, anxiety, and satisfaction in urban minority women with abnormal mammograms: a randomized controlled trial. J Urban Health. 2008;85(1):114–24.
14. Landercasper J, Linebarger JH, Ellis RL, et al. A quality review of the timeliness of breast cancer diagnosis and treatment in an integrated breast center. J Am Coll Surg. 2010;210(4):449–55.
15. Loftus L, Laronga C, Coyne K, Hildreth L. Race of the clock: reducing delay to curative breast cancer surgery. J Natl Compr Canc Netw. 2014;12 Suppl 1:S13–15.
16. Bleicher RJ, Ruth K, Sigurdson ER, et al. Time to surgery and breast cancer survival in the United States. JAMA Oncol. 2016;2(3):330–9.
17. Richards MA, Westcombe AM, Love SB, Littlejohns P, Ramirez AJ. Influence of delay on survival in patients with breast cancer: a systematic review. Lancet. 1999;353(9159):1119–26.
18. Killelea BK, Yang VQ, Wang SY, et al. Racial differences in the use and outcome of neoadjuvant chemotherapy for breast cancer: results from the National Cancer Data Base. J Clin Oncol. 2015;33(36):4267–76.
19. Tichy JR, Deal AM, Anders CK, Reeder-Hayes K, Carey LA. Race, response to chemotherapy, and outcome within clinical breast cancer subtypes. Breast Cancer Res Treat. 2015;150(3):667–74.
20. DeSantis CE, Siegel RL, Sauer AG, et al. Cancer statistics for African Americans, 2016: progress and opportunities in reducing racial disparities. CA Cancer J Clin. 2016;66(4):290–308.
21. Warner ET, Tamimi RM, Hughes ME, et al. Racial and ethnic differences in breast cancer survival: mediating effect of tumor characteristics and sociodemographic and treatment factors. J Clin Oncol. 2015;33(20):2254–61.
22. Shi R, Taylor H, McLarty J, Liu L, Mills G, Burton G. Effects of payer status on breast cancer survival: a retrospective study. BMC Cancer. 2015;15:211.
23. Bleicher RJ, Ruth K, Sigurdson ER, et al. Preoperative delays in the US Medicare population with breast cancer. J Clin Oncol. 2012;30(36):4485–92.
24. Kurian AW, Lichtensztajn DY, Keegan TH, Nelson DO, Clarke CA, Gomez SL. Use of and mortality after bilateral mastectomy compared with other surgical treatments for breast cancer in California, 1998–2011. JAMA. 2014;312(9):902–14.
25. van Maaren MC, de Munck L, de Bock GH, et al. Higher 10-year overall survival after breast conserving therapy compared to mastectomy in early stage breast cancer: a population-based study with 37,207 patients [Abstract No. S3-05]. Presented at the 38th Annual San Antonio Breast Cancer Symposium: 8–12 Dec 2015; San Antonio.
26. Dillman RO, Chico SD. Cancer patient survival improvement is correlated with the opening of a community cancer center: comparisons with intramural and extramural benchmarks. J Oncol Pract. 2005;1(3):84–92.
27. Hulvat M, Sandalow N, Rademaker A, Helenowski I, Hansen NM. Time from diagnosis to definitive operative treatment of operable breast cancer in the era of multimodal imaging. Surgery. 2010;148(4):746–50 (discussion 750–41).